{
    "Trade/Device Name(s)": [
        "Light Diagnostics HSV 1/2 Typing DFA Kit"
    ],
    "Submitter Information": "Millipore Corp. (formerly Chemicon International, Inc.)",
    "510(k) Number": "K081527",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GQL"
    ],
    "Summary Letter Date": "February 27, 2009",
    "Summary Letter Received Date": "March 3, 2009",
    "Submission Date": "May 29, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Herpes simplex virus type 1",
        "Herpes simplex virus type 2"
    ],
    "Specimen Type(s)": [
        "Direct specimens from patients with vesicular lesions",
        "Culture specimens"
    ],
    "Specimen Container(s)": [
        "Viral transport media",
        "Standard tubes for cell culture"
    ],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope with 100 watt mercury or halogen lamp, FITC filter set"
    ],
    "Method(s)/Technology(ies)": [
        "Direct immunofluorescence assay"
    ],
    "Methodologies": [
        "Immunofluorescence",
        "Monoclonal antibody staining"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Control Slide"
    ],
    "Document Summary": "FDA 510(k) summary for Light Diagnostics HSV 1/2 Typing DFA Kit using direct immunofluorescence assay to qualitatively detect and identify HSV-1 and HSV-2 in patient specimens and cell cultures.",
    "Indications for Use Summary": "Qualitative detection and identification of herpes simplex virus type 1 and/or type 2 in direct specimens from patients with vesicular lesions and symptoms of herpes infection, and for culture confirmation by immunofluorescence.",
    "fda_folder": "Microbiology"
}